NCT00679991 - A Phase 1-2 Study of PRT-201 Administered in Chronic Kidney Disease (CKD) Patients | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 30, 2008

Primary Completion Date

July 31, 2011

Study Completion Date

July 31, 2011

Conditions

Chronic Kidney Disease

Interventions

DRUG

PRT-201

Applied topically to AVF during surgery

DRUG

PRT-201

Dose escalation study. Drug/placebo administered at the time of fistula creation

Trial Locations (11)

Weill Cornell Medical College, New York

Sentara Medical Group, Norfolk

Duke University Medical Center, Durham

University of Cincinnati Medical Center, Cincinnati

Clarian Health Partners/Indiana University/Purdue University, Indianapolis

University of Iowa Hospitals and Clinics, Iowa City

Washington University in St. Louis, St Louis

The Methodist Hospital, Houston

Maine Medical Center, Portland

Brigham and Women's Hospital, Boston

Western New England Renal & Transplant Associates, Springfield